IL-21 uniquely contributes to SLE and other autoimmune diseases, because pharmacological and genetic abrogation of IL-21 signaling in mice stopped inflammation in non-lymphoid organs and protected them from autoimmune diseases, respectively (Choi et al., 2017; Liu and King, 2013). The gene discussed is IL21; the disease is autoimmune disease.